Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series - Wikidata - wikimedia - TriplyDB

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series

http://www.wikidata.org/entity/Q28264132

about

Review of screening for pancreatic cancer in high risk individuals Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism Perspectives in the treatment of pancreatic adenocarcinoma Screening for pancreatic cancer in familial high-risk individuals: A systematic review Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses Screening for Pancreatic Cancer.High risk factors of pancreatic carcinoma.Gastrointestinal tract cancers: Genetics, heritability and germ line mutations Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest Pancreatic cancer-improved care achievable The epidemiology of pancreatitis and pancreatic cancer.Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening Discovering the route from inflammation to pancreatic cancer.Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.The histopathology of PRSS1 hereditary pancreatitis.Genetic risk for alcoholic chronic pancreatitis Diagnosing and managing pancreatic cancer Hereditary pancreatic and hepatobiliary cancers Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.Epidemiology of Pancreatic and Periampullary Cancer.Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.A cost analysis of a pancreatic cancer screening protocol in high-risk populations.Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Hereditary pancreatitis of 3 Chinese children: Case report and literature review.Risk factors and therapeutic targets in pancreatic cancer.Total pancreatectomy for pancreatic cancer: indications and operative technique.Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.Familial pancreatic cancer: Concept, management and issues.Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.Selected medical conditions and risk of pancreatic cancer.Familial pancreatic cancer--current knowledge.Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012.Inflammation and pancreatic cancer: disease promoter and new therapeutic target.An overview of the diagnosis and management of nutrition in chronic pancreatitis.Treatment options for chronic pancreatitis.

P2860

Q24630198-8BF54094-0DD6-4CD1-A9CD-54629E9032E3 Q24650338-BC5AA496-6136-40CD-8E0D-BC16CCA294FA Q26797248-B0816B18-2DD6-4EC6-B4B4-9E3207B26CAD Q26801172-3A8F52EC-8205-47E0-A0B3-49A048733884 Q26996794-B7A9EF06-7EBB-494A-955B-1DABA7E5C98C Q27010209-DEA47C3D-D148-459A-8753-790B6B9F724B Q27022231-6E57DB1D-D4D2-474E-9B99-FAD715DF3D5C Q28249680-6532657C-0BC3-41B9-9464-DB88A6697DFA Q30240971-E7D5829A-527B-42DB-B633-312C0DF61DEF Q30249161-DE38DEEE-DD1F-41CF-973E-1C5E66E0209C Q33599436-9E402E5E-8801-4293-969B-80145A423E96 Q33759237-BC197BCD-0127-45B3-A3D0-A72FF31500C6 Q34036659-738EA987-7870-4110-81F7-8C6CA8492496 Q34341477-6C06229A-6334-4643-A892-3E99DE2EADC1 Q34405150-5812B08D-8C26-4887-B80D-C2D7A0730F03 Q34452269-94CCC30C-8A53-4E3C-9BC7-1B5E72E16BA3 Q34645978-636C1A24-56B0-41E0-8344-54DC732452BC Q34656874-8051B8FD-F983-4B08-B367-EACA37375A5E Q35063995-ADF2D19A-D944-4727-9E0C-2374E302A0D7 Q35162016-7691B398-FD2A-4C10-81B2-35E205EC405C Q35603086-36FAC78D-F794-4785-BA6F-46B9543F6F00 Q35692230-9B334A2E-061D-45C7-988C-FEB196439DD6 Q36347277-ADB29708-56D3-4D54-B43B-A7DDD20349E7 Q36400097-A694F765-164F-40B1-BD2D-EA18167E9400 Q36450022-F3E9D639-1317-4385-939D-8CAAF48A4143 Q36961232-DAD6683D-9561-4F89-B02E-EA9DA9CB9808 Q37129787-98EAE0A3-8768-4D60-AF34-90D9DF52519D Q37256871-BB8E6EFD-C271-4376-9AB6-FBEA93C315FD Q37317310-A843E74C-9753-43CF-BDF2-A0E9E824623B Q37374088-2554FF0F-5687-464C-B187-CB4B5E89AC7C Q37582401-E9A4A5CE-E024-4191-B191-920202B6F567 Q37644011-DA458C55-02D0-4FDE-AC29-52930ABEC151 Q37918870-71033BF2-2016-4752-8712-A092297BDB22 Q37967629-D72749B4-30EE-4A0E-B2DA-441994CCF7EB Q38016055-772D1DD9-EB39-46CA-BF21-243922861851 Q38031421-D6E99229-043B-430D-A0E2-6986FD2597EC Q38100643-150EE165-406E-4D8E-8BAC-9D698898CE16 Q38167608-61C1F705-E8F5-4342-AB4F-B688316D56D7 Q38205327-A2236AC7-75E1-4889-A3A0-FA3E47602797 Q38218834-8F506522-1DA9-4C3C-8B1C-569BEF60C97D

P2860

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series

http://www.wikidata.org/entity/Q28264132

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@ast

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@en

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@nl

type

label

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@ast

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@en

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@nl

prefLabel

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@ast

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@en

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@nl

P1433

Q28264132-A7E89728-B3F4-4BE0-AC60-9AEB60F3804A

P1476

Q28264132-D4D33DCB-C55D-40B9-9BFA-8C4D9AAAAC4C

P2093

Q28264132-2B09C746-FAA8-4282-B329-33FD6D100AB1

Q28264132-33C2CE39-03AF-4C52-A8C0-94AF846E2A17

Q28264132-4546A170-E488-4585-8BD7-E53054C1B203

Q28264132-4A74E705-3468-4C56-ADB8-63F3DAC20E71

Q28264132-8FB316FC-A95F-4EA5-9D27-7AB40659B069

Q28264132-DE049792-01E0-4F14-A674-F290162EE151

Q28264132-F6A2DDFB-B27E-49AE-BB2B-D399F78AD48C

P2860

Q28264132-56536EB8-F743-41D6-A5BC-D65E189074BA

Q28264132-730D8144-D7F0-4588-9D88-82A0F662B252

Q28264132-D5DB6B6F-DD41-4B85-831A-8B9519838DC3

P304

Q28264132-B7D30E5C-9102-4B72-ACCA-645F54BD2098

P31

Q28264132-3FE5041D-5C03-4AA8-9E4C-8C7FD2710CE7

P3181

Q28264132-149B6C1A-1D42-4A9A-9F8E-2ADBF01E112F

P356

Q28264132-A3A86D53-B89B-4638-89C3-D1C719037814

P407

Q28264132-762872AA-CF65-44C5-811D-D90D4D56297E

P433

Q28264132-F0CB1CE5-D912-4599-9129-FEB498476786

P478

Q28264132-E49A878F-8616-433B-8DB4-3C0BF6528AF5

P50

Q28264132-3BE901E3-6BAD-4D7A-A3F0-115A20066169

P577

Q28264132-66AE87B1-B1AC-4C8D-992D-21BFB944168E

P5875

Q28264132-457F473C-997A-4639-9B82-58985D33D69E

P698

Q28264132-1C3DA27E-241A-41C0-9059-596E9F3C11AA

P921

Q28264132-65EAEBA6-18B1-4CFF-B870-ED89B6915423

Q28264132-E5C871ED-6AE8-44A7-B812-E187C7552353

P3181

P356

J.1572-0241.2007.01597.X

P1433

The American Journal of Gastroenterology

P1476

Risk of pancreatic adenocarcin ...... : a national exhaustive series

@en

P2093

Claude Férec

http://www.w3.org/2001/XMLSchema#string

Frédérique Maire

http://www.w3.org/2001/XMLSchema#string

Matthieu Schnee

http://www.w3.org/2001/XMLSchema#string

Pascal Hammel

http://www.w3.org/2001/XMLSchema#string

Philippe Lévy

http://www.w3.org/2001/XMLSchema#string

Philippe Ruszniewski

http://www.w3.org/2001/XMLSchema#string

Vinciane Rebours

http://www.w3.org/2001/XMLSchema#string

P2860

A method for estimating the probability of adverse drug reactions

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Sildenafil-associated hepatotoxicity.

P304

111-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3747359

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1572-0241.2007.01597.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Christine Boutron-Ruault

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5666551

http://www.w3.org/2001/XMLSchema#string

P698

18184119

http://www.w3.org/2001/XMLSchema#string

P921